Insight Molecular Diagnostics (IMDX) Cash from Operations Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) Cash from Operations Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -101.15% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 64.87% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.77% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 11.89% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 25.34% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -9.63% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 8.80% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 20.42% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -28.11% |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 | -30.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.83% |
| Dec 31, 2025 | -3.63% |
| Sep 30, 2025 | 18.59% |
| Jun 30, 2025 | -5.35% |
| Mar 31, 2025 | -52.45% |
| Dec 31, 2024 | -20.95% |
| Sep 30, 2024 | -46.72% |
| Jun 30, 2024 | 12.50% |
| Mar 31, 2024 | 53.86% |
| Dec 31, 2023 | 54.15% |
| Sep 30, 2023 | 66.93% |
| Jun 30, 2023 | 39.25% |
| Mar 31, 2023 | 37.49% |
| Dec 31, 2022 | -36.56% |
| Sep 30, 2022 | -3.76% |
| Jun 30, 2022 | -39.58% |
| Mar 31, 2022 | -35.00% |
| Dec 31, 2021 | -14.99% |
| Sep 30, 2021 | -82.90% |
| Jun 30, 2021 | -15.76% |